Holen Sie sich die Stockscreener-App
20.15
0.70%
0.14
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.84%
31.69
|
26.90 | 27.07 | 24.60 | 25.99 |
| Operating Income/Loss |
17.84%
-31.69
|
-26.90 | -27.07 | -24.60 | -25.99 |
| Nonoperating Income/Loss |
15.26%
3.149
|
3.716 | 3.912 | 4.653 | 3.249 |
| Income/Loss From Continuing Operations Before Tax |
23.14%
-28.54
|
-23.18 | -23.16 | -19.95 | -22.74 |
| Income/Loss From Continuing Operations After Tax |
23.14%
-28.54
|
-23.18 | -23.16 | -19.95 | -22.74 |
|
Net Income/Loss
|
23.14%
-28.54
|
-23.18 | -23.16 | -19.95 | -22.74 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,251%
50.05
|
0.9354 | 48.27 | 48.08 | 42.05 |
| Diluted Average Shares |
5,251%
50.05
|
0.9354 | 48.27 | 48.08 | 42.05 |
| Basic Earnings Per Share |
23.91%
-0.57
|
-0.46 | -0.48 | -0.41 | -0.54 |
| Diluted Earnings Per Share |
23.91%
-0.57
|
-0.46 | -0.48 | -0.41 | -0.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):